Skip to main content
Top
Published in: BMC Cancer 1/2005

Open Access 01-12-2005 | Research article

Cancer incidence in Arkhangelskaja Oblast in northwestern Russia. The Arkhangelsk Cancer Registry

Authors: Arild Vaktskjold, Jelena A Lebedintseva, Dmitrij S Korotov, Anatolij V Tkatsjov, Tatjana S Podjakova, Eiliv Lund

Published in: BMC Cancer | Issue 1/2005

Login to get access

Abstract

Background

Data concerning incidence and prevalence of cancer in the different regions of Russia have traditionally not been provided on a basis that facilitated comparison with data from countries in western parts of Europe. The oncological hospital in Arkhangelsk, in co-operation with Universitetet i Tromsø (Norway), has established a population based cancer registry for Arkhangelskaja Oblast (AO). AO is an administrative unit with 1.3 million inhabitants in northwestern Russia. The aim of this investigation was to assess the content and quality of the AO cancer registry (AKR), and to present the site-specific cancer-incidence rates in AO in the period 1993–2001.

Methods

The population in this study consisted of all individuals registered as residents of AO. All new cancer cases in the period 1993 – 2001, registered the AKR, were included in the study (ICD-10: C00-C95, except for C77-78). The annual gender and age-group-specific population figures were obtained from the AO statistics office.

Results

A total of 34 697 cases of primary cancers were included. The age-adjusted (world standard) incidence rate for all sites combined was 164/100 000 for women and 281/100 000 for men. The highest incidence was for cancer of the trachea, bronchus and lung (16.3% of all cases), whereof 88.6 % of the cases were among men. Among women, cancer of the breast constituted 15.9 percent of all cases. The age-adjusted incidences of the most frequent cancer sites among men were: lung (77.4/100 000); stomach (45.9); rectum (13.4); oesophagus (13.0); colon (12.2); bladder (11.6); and prostate cancer (11.1). Among women they were: breast (28.5); stomach (19.7); colon (12.2); and ovary cancer (9.0).

Conclusion

Our findings confirm and strengthen the indication that the incidences of stomach, larynx, liver, pancreas, prostate, colon, bladder and melanoma cancer are quite different in male populations in Russia compared to many other European countries. Among women, most major cancer types, except stomach, appear to be relatively low in Russian populations. The AKR provides quality data for estimations and insight to the cancer incidence in a northern Russian population, and we consider the reported incidence rates to reflect the cancer situation in AO well.
Appendix
Available only for authorised users
Literature
2.
go back to reference Merabishvili VM, Starinskii VV, Remennik LV: [All-Russia symposium on issues in establishing and development of cancer registries]. Vopr Onkol. 1999, 45: 588-590. Merabishvili VM, Starinskii VV, Remennik LV: [All-Russia symposium on issues in establishing and development of cancer registries]. Vopr Onkol. 1999, 45: 588-590.
3.
go back to reference AMAP Secretariat: Updating of Environmental "Hot Spots" List in the Russian Part of the Barents Region. 2004, Oslo AMAP Secretariat: Updating of Environmental "Hot Spots" List in the Russian Part of the Barents Region. 2004, Oslo
4.
go back to reference Tsentr gosudarstvennovo sanitarno – epidemiologitjseskovo nadzora v Arkhangeljskoj oblasti: O sanitarno-epidemiologitsjeskoj obstanovkje v Arkhangeljskoj oblasti v 2001 godu [in Russian]. 2002, Arkhangelsk Tsentr gosudarstvennovo sanitarno – epidemiologitjseskovo nadzora v Arkhangeljskoj oblasti: O sanitarno-epidemiologitsjeskoj obstanovkje v Arkhangeljskoj oblasti v 2001 godu [in Russian]. 2002, Arkhangelsk
5.
go back to reference Smetanin AV: Arkhangelskaja oblast: mjezjdu prosjlym i budusjim [in Russian]. 2002, Arkhangelsk: Izdatelstvo Pravda severa Smetanin AV: Arkhangelskaja oblast: mjezjdu prosjlym i budusjim [in Russian]. 2002, Arkhangelsk: Izdatelstvo Pravda severa
6.
go back to reference Gosudarstvennyj komitet po okhrane okruzjajostsjej sredy Arkhangelskoj oblasti: Evropeiskij sever Rossii: Ekologija bez granits [in Russian]. 2000, Arkhangelsk: Arkhangelskij oblastnoj komitet gosudarstvennoj statistiki Gosudarstvennyj komitet po okhrane okruzjajostsjej sredy Arkhangelskoj oblasti: Evropeiskij sever Rossii: Ekologija bez granits [in Russian]. 2000, Arkhangelsk: Arkhangelskij oblastnoj komitet gosudarstvennoj statistiki
7.
go back to reference Kreftregisteret: [Cancer in Norway 1993]. 1996, Oslo Kreftregisteret: [Cancer in Norway 1993]. 1996, Oslo
8.
go back to reference Maclennan R: Items of patient information which may be collected by registries. Cancer registration principles and methods. Edited by: Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. 1991, Lyon: IARC, 43-63. Maclennan R: Items of patient information which may be collected by registries. Cancer registration principles and methods. Edited by: Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. 1991, Lyon: IARC, 43-63.
9.
go back to reference Jacobsen R, Norstein J: Erroneous cancer diagnoses in hospital patient administrative systems [abstract]. Int J Cancer . 2002, s177-Suppl 13 Jacobsen R, Norstein J: Erroneous cancer diagnoses in hospital patient administrative systems [abstract]. Int J Cancer . 2002, s177-Suppl 13
10.
go back to reference Izdatelstvo meditsina: Statistitjeskjie materiali [in Russian]. Zdravooxranenie Russiskoj federatsii. 2002, 32: 1-32. Izdatelstvo meditsina: Statistitjeskjie materiali [in Russian]. Zdravooxranenie Russiskoj federatsii. 2002, 32: 1-32.
11.
go back to reference Arkhangelskij oblkomstat: Raspredelenie naselenija po polu i vozrastu po dannym Vserossijskoj perepis naselenija 2002 goda [in Russian]. 2004, Arkhangelsk Arkhangelskij oblkomstat: Raspredelenie naselenija po polu i vozrastu po dannym Vserossijskoj perepis naselenija 2002 goda [in Russian]. 2004, Arkhangelsk
12.
go back to reference Shkolnikov VM, McKee M, Vallin J, Aksel E, Leon D, Chenet L, Mesle F: Cancer mortality in Russia and Ukraine: validity, competing risks and cohort effects. Int J Epidemiol. 1999, 28: 19-29. 10.1093/ije/28.1.19.CrossRefPubMed Shkolnikov VM, McKee M, Vallin J, Aksel E, Leon D, Chenet L, Mesle F: Cancer mortality in Russia and Ukraine: validity, competing risks and cohort effects. Int J Epidemiol. 1999, 28: 19-29. 10.1093/ije/28.1.19.CrossRefPubMed
13.
go back to reference Kreftregisteret: [Cancer in Norway 2000]. 2002, Oslo Kreftregisteret: [Cancer in Norway 2000]. 2002, Oslo
14.
go back to reference Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999, 80: 827-841. 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P.CrossRefPubMed Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999, 80: 827-841. 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P.CrossRefPubMed
15.
go back to reference Merabishvili VM, Popova SP, Urmancheeva AF, Vishnevskii AS, Safronnikova NR, Protasov DA: [Assessment of cancer morbidity and treatment for female genital tumors in St.Petersburg]. Vopr Onkol. 1999, 45: 233-237.PubMed Merabishvili VM, Popova SP, Urmancheeva AF, Vishnevskii AS, Safronnikova NR, Protasov DA: [Assessment of cancer morbidity and treatment for female genital tumors in St.Petersburg]. Vopr Onkol. 1999, 45: 233-237.PubMed
16.
go back to reference The Cancer Registry of Norway: Trends in cancer incidence in Norway 1955-67. 1972, Oslo The Cancer Registry of Norway: Trends in cancer incidence in Norway 1955-67. 1972, Oslo
Metadata
Title
Cancer incidence in Arkhangelskaja Oblast in northwestern Russia. The Arkhangelsk Cancer Registry
Authors
Arild Vaktskjold
Jelena A Lebedintseva
Dmitrij S Korotov
Anatolij V Tkatsjov
Tatjana S Podjakova
Eiliv Lund
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2005
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-5-82

Other articles of this Issue 1/2005

BMC Cancer 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine